Katz AE - Search Results

1

RT-PCR for PSA as a prognostic factor for patients with clinically localized prostate cancer treated with radiotherapy.

Gewanter RM, Katz AE, Olsson CA, Benson MC, Singh A, Schiff PB, Ennis RD. Gewanter RM, et al. Among authors: katz ae. Urology. 2003 May;61(5):967-71. doi: 10.1016/s0090-4295(02)02581-5. Urology. 2003. PMID: 12736017

2

Characterization of the products of a gene expressed during androgen-programmed cell death and their potential use as a marker of urogenital injury.

Bandyk MG, Sawczuk IS, Olsson CA, Katz AE, Buttyan R. Bandyk MG, et al. Among authors: katz ae. J Urol. 1990 Feb;143(2):407-13. doi: 10.1016/s0022-5347(17)39975-5. J Urol. 1990. PMID: 2299741 Free article.

3

Gene activity during the early phase of androgen-stimulated rat prostate regrowth.

Katz AE, Benson MC, Wise GJ, Olsson CA, Bandyk MG, Sawczuk IS, Tomashefsky P, Buttyan R. Katz AE, et al. Cancer Res. 1989 Nov 1;49(21):5889-94. Cancer Res. 1989. PMID: 2571413

4

PSA density (PSAD). Role in patient evaluation and management.

Seaman E, Whang M, Olsson CA, Katz A, Cooner WH, Benson MC. Seaman E, et al. Urol Clin North Am. 1993 Nov;20(4):653-63. Urol Clin North Am. 1993. PMID: 7505973

5

Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay.

Katz AE, Olsson CA, Raffo AJ, Cama C, Perlman H, Seaman E, O'Toole KM, McMahon D, Benson MC, Buttyan R. Katz AE, et al. Urology. 1994 Jun;43(6):765-75. doi: 10.1016/0090-4295(94)90132-5. Urology. 1994. PMID: 7515202

6

Molecular staging of prostate cancer. II. A comparison of the application of an enhanced reverse transcriptase polymerase chain reaction assay for prostate specific antigen versus prostate specific membrane antigen.

Cama C, Olsson CA, Raffo AJ, Perlman H, Buttyan R, O'Toole K, McMahon D, Benson MC, Katz AE. Cama C, et al. Among authors: katz ae. J Urol. 1995 May;153(5):1373-8. J Urol. 1995. PMID: 7536252 Free article.

7

Preoperative reverse transcriptase polymerase chain reaction for prostate specific antigen predicts treatment failure following radical prostatectomy.

Olsson CA, de Vries GM, Raffo AJ, Benson MC, O'Toole K, Cao Y, Buttyan RE, Katz AE. Olsson CA, et al. Among authors: katz ae. J Urol. 1996 May;155(5):1557-62. J Urol. 1996. PMID: 8627821 Free article.

8

Molecular staging of genitourinary malignancies.

Katz AE, De Vries GM, Olsson CA, Benson MC, Swanton P, Ikeguchi EF, Buttyan R. Katz AE, et al. Urology. 1996 Jun;47(6):948-58. doi: 10.1016/S0090-4295(96)00110-0. Urology. 1996. PMID: 8677601 Free article. Review. No abstract available.

9

The use of RT-PCR for prostate-specific antigen assay to predict potential surgical failures before radical prostatectomy: molecular staging of prostate cancer.

Olsson CA, De Vries GM, Benson MC, Raffo A, Buttyan R, Cama C, O'Toole K, Katz AE. Olsson CA, et al. Among authors: katz ae. Br J Urol. 1996 Mar;77(3):411-7. doi: 10.1046/j.1464-410x.1996.90616.x. Br J Urol. 1996. PMID: 8814848

10

Enhanced reverse transcriptase-polymerase chain reaction for prostate specific antigen as an indicator of true pathologic stage in patients with prostate cancer.

Katz AE, de Vries GM, Begg MD, Raffo AJ, Cama C, O'Toole K, Buttyan R, Benson MC, Olsson CA. Katz AE, et al. Cancer. 1995 Apr 1;75(7):1642-8. doi: 10.1002/1097-0142(19950401)75:7<1642::aid-cncr2820750714>3.0.co;2-1. Cancer. 1995. PMID: 8826922

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

175 results

Search Page

Filters